In vitro transforming potential, intracellular signaling properties and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu and Arg886Trp

Endocr Relat Cancer. 2016 Dec;23(12):X1. doi: 10.1530/ERC-10-0258a.
No abstract available

Publication types

  • Published Erratum